Envoy Medical, Inc. Reports Q3 2026 Financial Results

What Happened
Envoy Medical, Inc. (COCH) filed a Form 8-K on August 10, 2026 (Item 2.02) to announce its results of operations and financial condition for the fiscal quarter ended June 30, 2026. The company issued a press release reporting its quarterly results; that release is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: August 10, 2026 (Form 8-K, Item 2.02).
• Reporting period: fiscal quarter ended June 30, 2026.
• Exhibit included: Press Release dated August 10, 2026 (Exhibit 99.1).
• Inline XBRL Cover Page Interactive Data File included (Exhibit 104).

Why It Matters
This 8-K makes Envoy’s quarterly earnings and other financial results public. Retail investors should review the attached press release for specifics on revenue, net income or loss, cash position and any management commentary or guidance, since those figures directly affect valuation, near-term expectations, and trading decisions. The press release and the company’s SEC filings are the primary sources for the concrete numbers and context.